Research

Depression and Quality of Life in Cancer Patients Undergoing Chemotherapy: Relation between the Zung Self-Rating Depression Scale and Functional Assessment of Cancer Therapy-General


 

Objective: Although depression is prevalent among cancer patients, it remains underdiagnosed and undertreated. Quality of life is an important outcome in cancer patients and can be measured by questionnaires such as the Functional Assessment of Cancer Therapy-General version (FACT-G). The purpose of our study was to establish whether or not a group of items in FACT-G could be used as a screening tool for depression as well as for assessing quality of life.

Methods: A total of 62 chemotherapy patients (median age, 62 years [range, 22-81 years]; 55% women) completed Zung Self-Rating Depression Scale (ZSDS) and FACT-G questionnaires. Patients with ZSDS scores of 40 or more underwent clinical interviews for major depression. Pearson’s correlation was used to examine the relationship between the ZSDS and FACT-G scores. FACT-G score results were then analyzed to evaluate if subsets of the FACT-G can be used as a screening tool for major depression.

Results: In all, 30 of 62 patients (48%) had ZSDS scores less than 40 and were ruled out for major depression, and 30 of the 32 patients with ZSDS scores greater or equal to 40 participated in clinical interviews. Of those who were interviewed, 7 patients (23%) were confirmed to have major depression. Overall, the prevalence of major depression was 7 of 60 patients (12%; 95% CI: 5%-23%). The ZSDS and FACT-G scores had strong correlation (r -0.75). The composite score of six statements in FACT-G were found to have sensitivity of 100% and specificity of 81% in predicting major depression, using a cut-off value of 12 (range, 0-24). The six statements were, I have a lack of energy; I feel sad; I feel nervous; I am able to enjoy life; I am sleeping well; and I am enjoying the things I usually do for fun.

Conclusions: The prevalence of major depression among all participants was 12%. The ZSDS score and FACT-G score had strong correlation; the subsets of FACT-G may be useful as a screening tool for depression.


*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

Study: Myeloma Survival Gains, but QOL Slides
MDedge Hematology and Oncology
Late Oral Complications After Head/Neck Radiation 'Underreported'
MDedge Hematology and Oncology
Antinausea Gel Not Absorbed at Therapeutic Levels
MDedge Hematology and Oncology
Music Interventions Improve Anxiety, Pain in Cancer Patients
MDedge Hematology and Oncology
The Role of Spirituality and Religious Coping in the Quality of Life of Patients With Advanced Cancer Receiving Palliative Radiation Therapy
MDedge Hematology and Oncology
Spiritual Well-Being and Quality of Life of Women with Ovarian Cancer and Their Spouses
MDedge Hematology and Oncology
Palonosetron Plus 1-Day Dexamethasone for the Prevention of Nausea and Vomiting Due to Moderately Emetogenic Chemotherapy: Effect of Established Risk Factors on Treatment Outcome in a Phase III Trial
MDedge Hematology and Oncology
Neoplastic Meningitis
MDedge Hematology and Oncology
'Scrambler' Device Reduces Refractory Neuropathic Pain
MDedge Hematology and Oncology
Long-Acting ESA Approved to Treat Anemia in Dialysis Patients
MDedge Hematology and Oncology